RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier
RXRalpha 和 PPARdelta 信号作为血脑屏障的新型调节剂
基本信息
- 批准号:8660105
- 负责人:
- 金额:$ 38.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgonistAngiotensin IIAstrocytesBiological ModelsBloodBlood - brain barrier anatomyBlood CirculationBlood VesselsBrainBrain DiseasesCell Culture TechniquesCell modelCharacteristicsCuesDataDevelopmentDevelopmental ProcessDiseaseEmbryoEmbryonic DevelopmentEndothelial CellsEndotheliumFunctional disorderGene ExpressionGene Expression ProfilingGeneticGenetic TranscriptionHeterodimerizationHeterozygoteHomeostasisHumanIn VitroInvadedKnockout MiceKnowledgeLiverLungMaintenanceMesodermModelingMolecularMonitorMultiple SclerosisMusMutant Strains MiceNeonatalNeuraxisNeuronsNuclear ReceptorsPPAR deltaPathologyPathway interactionsPatientsPericytesPeripheralPermeabilityPhasePhenotypePlayPluripotent Stem CellsProcessPropertyReceptor SignalingRegulationResearchRoleSignal PathwaySignal TransductionStrokeSupporting CellSystemTamoxifenTestingTight JunctionsTransport ProcessUndifferentiatedWorkbeta catenincell typefetalgenetic analysisin vivoinsightmouse modelnerve stem cellnervous system disorderneurovascular unitnovelpostnatalprogramspublic health relevancereceptorrestorationsmoothened signaling pathway
项目摘要
DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) acts as a signaling and transport interface between the blood and brain. The BBB begins to form early in embryonic development as the mesoderm-derived vasculature invades the immature central nervous system (CNS) and begins to gain BBB characteristics such as tight junctions and a lack of fenestrae. After further maturation, the adult BBB, with its very low permeability and a wealth of molecular transport systems, is maintained by interactions with supporting cells of the neurovascular unit. While recent studies have indicated the importance of Wnt/beta- catenin, angiotensin II, and sonic hedgehog signaling on BBB development, many BBB attributes remain unaffected when these pathways are disrupted. Thus, our understanding of the molecular mechanisms underpinning BBB formation is incomplete, and in this proposal we aim to further examine the mechanisms that regulate BBB development and maintenance. Recently, we have identified nuclear receptors RXRalpha and PPARdelta as two potential regulators of BBB function. As described in the preliminary data, these receptors are specifically expressed at the BBB compared to peripheral endothelia, receptor agonists can drive BBB phenotypes in endothelial cells differentiated from human pluripotent stem cells (hPSC-derived BMECs), and endothelial-specific deletion of these receptors results in partial neonatal lethality (RXRalpha) and a leaky BBB (PPARdelta) in vivo. Thus, we hypothesize that the nuclear receptors RXRalpha and PPARdelta are crucial regulators of BBB development and maintenance. To test our hypothesis, we will evaluate the in vivo BBB phenotype upon embryonic and postnatal endothelial-specific deletion of RXRalpha and PPARdelta in mice. The molecular mechanisms governed by RXRalpha and PPARdelta activation will be evaluated using the differentiation process of hPSC-derived BMECs as a window to human BBB induction and maintenance. Finally, potential synergy on BBB formation arising from RXRalpha and PPARdelta co-activation will be assessed in vivo and in vitro. Understanding the regulators of BBB induction could yield many new insights regarding fetal brain disease. Furthermore, knowledge of the barrier-genesis and barrier maintenance pathways could open new avenues for restoring BBB function in debilitating neurological disease.
描述(由申请人提供):血脑屏障(BBB)充当血液和大脑之间的信号传导和运输界面。随着中胚层衍生的脉管系统侵入未成熟的中枢神经系统(CNS),BBB在胚胎发育的早期开始形成,并开始获得BBB特征,例如紧密连接和缺乏Fenestrae。进一步成熟后,成年BBB具有非常低的渗透性和大量分子运输系统,可以通过与神经血管单元的支持细胞相互作用来维持。虽然最近的研究表明Wnt/β-蛋白蛋白,血管紧张素II和Sonic刺猬信号在BBB发育中的重要性,但当这些途径被破坏时,许多BBB属性仍未受到影响。因此,我们对基于BBB形成的分子机制的理解是不完整的,在此提案中,我们旨在进一步研究调节BBB发育和维持的机制。最近,我们将核受体rxralpha和ppardelta确定为BBB功能的两个潜在调节剂。如初步数据中所述,与周围内皮的受体激动剂相比,这些受体在BBB上特异性表达,可以驱动与人多能干细胞(HPSC衍生的BMEC)和内皮特异性缺失的内皮细胞中BBB表型的驱动。导致部分新生儿致死性(Rxralpha)和体内漏水的BBB(Ppardelta)。因此,我们假设核受体rxralpha和ppardelta是BBB发育和维持的关键调节剂。为了检验我们的假设,我们将评估小鼠rxralpha和ppardelta的胚胎和产后内皮特异性缺失后体内BBB表型。由Rxralpha和Ppardelta激活控制的分子机制将使用HPSC衍生的BMEC的分化过程进行评估,以作为人类BBB诱导和维持的窗口。最后,将在体内和体外评估由rxralpha和ppardelta共激活引起的BBB形成的潜在协同作用。了解BBB诱导的调节剂可能会产生有关胎儿脑疾病的许多新见解。此外,对障碍生成和障碍维护途径的了解可能会为恢复BBB功能的新途径在使神经系统疾病的衰弱中恢复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC V SHUSTA其他文献
ERIC V SHUSTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC V SHUSTA', 18)}}的其他基金
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
- 批准号:
10581615 - 财政年份:2021
- 资助金额:
$ 38.12万 - 项目类别:
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
- 批准号:
10208481 - 财政年份:2021
- 资助金额:
$ 38.12万 - 项目类别:
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
- 批准号:
10376351 - 财政年份:2021
- 资助金额:
$ 38.12万 - 项目类别:
Investigating Pericyte Roles in Blood-Brain Barrier Formation
研究周细胞在血脑屏障形成中的作用
- 批准号:
9975931 - 财政年份:2018
- 资助金额:
$ 38.12万 - 项目类别:
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
探索阿尔茨海默病中的血脑屏障功能障碍
- 批准号:
10470403 - 财政年份:2018
- 资助金额:
$ 38.12万 - 项目类别:
Investigating Pericyte Roles in Blood-Brain Barrier Formation
研究周细胞在血脑屏障形成中的作用
- 批准号:
10390466 - 财政年份:2018
- 资助金额:
$ 38.12万 - 项目类别:
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
探索阿尔茨海默病中的血脑屏障功能障碍
- 批准号:
10242177 - 财政年份:2018
- 资助金额:
$ 38.12万 - 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
- 批准号:
9920222 - 财政年份:2017
- 资助金额:
$ 38.12万 - 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
- 批准号:
10186832 - 财政年份:2017
- 资助金额:
$ 38.12万 - 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
- 批准号:
9380557 - 财政年份:2017
- 资助金额:
$ 38.12万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
cAMP信号激动剂对恶性胶质瘤血管新生和血管正常化的影响及机制研究
- 批准号:81803568
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Role of SIK3 in PKA/mTORC1 regulation of adipose browning
SIK3 在 PKA/mTORC1 调节脂肪褐变中的作用
- 批准号:
10736962 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Compartmentalized signaling and crosstalk in airway myocytes
气道肌细胞中的区室化信号传导和串扰
- 批准号:
10718208 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
Investigating non-canonical mechanisms of endogenous opioids on motivation in dorsal midbrain
研究内源性阿片类药物对背侧中脑动机的非典型机制
- 批准号:
10624699 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别:
A functional characterization of Brugia malayi GABA-gated chloride channels: an unexplored target for antifilarial therapeutics
马来丝虫 GABA 门控氯离子通道的功能表征:抗丝虫治疗的未探索靶点
- 批准号:
10742453 - 财政年份:2023
- 资助金额:
$ 38.12万 - 项目类别: